RedHill Biopharma Ltd. (RDHL)
USD 2.29
(2.23%)
USD 2.29
(2.23%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 3.69 USD | 109.62% |
| 2022 | -38.27 USD | 61.06% |
| 2021 | -98.27 USD | -0.53% |
| 2020 | -97.75 USD | -66.3% |
| 2019 | -58.78 USD | 13.56% |
| 2018 | -68.00 USD | 34.62% |
| 2017 | -104.00 USD | -9.52% |
| 2016 | -94.96 USD | -24.73% |
| 2015 | -76.13 USD | -53.89% |
| 2014 | -49.47 USD | 27.41% |
| 2013 | -68.15 USD | 14.81% |
| 2012 | -80.00 USD | 37.97% |
| 2011 | -128.96 USD | -566.46% |
| 2010 | -19.35 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 Q2 | 0.19 USD | -99.07% |
| 2023 Q1 | 20.44 USD | 1810.28% |
| 2023 FY | - USD | 109.62% |
| 2022 Q3 | -40.29 USD | -301.29% |
| 2022 Q1 | -13.36 USD | 32.01% |
| 2022 Q2 | -10.04 USD | 24.85% |
| 2022 FY | - USD | 61.06% |
| 2022 Q4 | 1.07 USD | 102.66% |
| 2021 Q2 | -24.95 USD | -17.19% |
| 2021 Q3 | -18.28 USD | 26.73% |
| 2021 Q4 | -19.65 USD | -7.49% |
| 2021 FY | - USD | -0.53% |
| 2021 Q1 | -21.29 USD | 17.13% |
| 2020 FY | - USD | -66.3% |
| 2020 Q1 | -19.46 USD | -40.1% |
| 2020 Q2 | -17.95 USD | 7.76% |
| 2020 Q3 | -19.99 USD | -11.36% |
| 2020 Q4 | -25.69 USD | -28.51% |
| 2019 Q3 | -13.87 USD | 9.82% |
| 2019 Q1 | -13.92 USD | -19.18% |
| 2019 Q2 | -15.38 USD | -10.49% |
| 2019 FY | - USD | 13.56% |
| 2019 Q4 | -13.89 USD | -0.14% |
| 2018 FY | - USD | 34.62% |
| 2018 Q4 | -11.68 USD | 31.97% |
| 2018 Q3 | -17.17 USD | 17.61% |
| 2018 Q2 | -20.84 USD | -11.8% |
| 2018 Q1 | -18.64 USD | 9.95% |
| 2017 Q3 | -36.14 USD | -40.68% |
| 2017 Q4 | -20.70 USD | 42.72% |
| 2017 FY | - USD | -9.52% |
| 2017 Q2 | -25.69 USD | -27.05% |
| 2017 Q1 | -20.22 USD | 15.75% |
| 2016 FY | - USD | -24.73% |
| 2016 Q4 | -24.00 USD | 14.5% |
| 2016 Q3 | -28.07 USD | -36.39% |
| 2016 Q2 | -20.58 USD | -18.41% |
| 2016 Q1 | -17.38 USD | 17.4% |
| 2015 Q1 | -19.82 USD | 18.27% |
| 2015 FY | - USD | -53.89% |
| 2015 Q4 | -21.04 USD | -95.9% |
| 2015 Q3 | -10.74 USD | 59.52% |
| 2015 Q2 | -26.53 USD | -33.85% |
| 2014 FY | - USD | 27.41% |
| 2014 Q4 | -24.25 USD | -25.78% |
| 2014 Q2 | -20.67 USD | -229.19% |
| 2014 Q1 | 16.00 USD | 174.52% |
| 2014 Q3 | -19.28 USD | 6.72% |
| 2013 FY | - USD | 14.81% |
| 2013 Q2 | -16.25 USD | -25.19% |
| 2013 Q1 | -12.98 USD | 48.7% |
| 2013 Q3 | -17.24 USD | -6.09% |
| 2013 Q4 | -21.47 USD | -24.54% |
| 2012 Q4 | -25.30 USD | -69.57% |
| 2012 Q1 | -20.90 USD | -4.45% |
| 2012 Q3 | -14.92 USD | 14.01% |
| 2012 Q2 | -17.35 USD | 16.99% |
| 2012 FY | - USD | 37.97% |
| 2011 FY | - USD | -566.46% |
| 2011 Q3 | -22.70 USD | 0.0% |
| 2011 Q4 | -20.01 USD | 11.85% |
| 2010 FY | - USD | 0.0% |